室内のラドン,肺外遺伝的リスク?

Human 3D multicellular microtissues: An upgraded model for the in vitro mechanistic investigation of inflammation-associated drug toxicity.

Toxicology letters·2019

ToxDB: pathway-level interpretation of drug-treatment data.

Database : the journal of biological databases and curation·2016

Toxicogenomic profiles in relation to maternal immunotoxic exposure and immune functionality in newborns.

Toxicological sciences : an official journal of the Society of Toxicology·2012

Mode matching with a single thin lens.

Applied optics·2010

Hereditary motor and sensory neuropathy (HMSN) IA, developmental delay and autism related disorder in a boy with duplication (17)(p11.2p12).

Genetic counseling (Geneva, Switzerland)·2004

A patient with a de novo 11q24.2-->qter deletion.

Genetic counseling (Geneva, Switzerland)·2004

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

Erratum: Defining the optimal imaging time point for fluorescence-lifetime-based tumor identification using the non-targeting near-infrared dye indocyanine green and post-processed high-dynamic-range images: errata.

Biomedical optics express·2026

Low-Dose Radiotherapy for Benign Achillodynia: A Single Center Experience With Prospective Follow-Up.

Cureus·2026

Microfluidic Isolation of Aptamers for Intracellular Measurement of Radio-Responsive Proteins.

Radiation (Multidisciplinary Digital Publishing Institute)·2026

Microenvironmental remodeling in FLASH radiotherapy.

Frontiers in cell and developmental biology·2026

Open Boari Flap Ureteroneocystostomy in a Radiated Pelvis: A Durable Solution for Complex Distal Ureteric Strictures.

Annals of African medicine·2026

Definitive carbon ion radiotherapy for thoracic bone and soft tissue sarcoma.

BMC cancer·2026

関連する実験動画

室内のラドン,肺外遺伝的リスク?

関連する概念動画

Human 3D multicellular microtissues: An upgraded model for the in vitro mechanistic investigation of inflammation-associated drug toxicity.

ToxDB: pathway-level interpretation of drug-treatment data.

Toxicogenomic profiles in relation to maternal immunotoxic exposure and immune functionality in newborns.

Mode matching with a single thin lens.

Hereditary motor and sensory neuropathy (HMSN) IA, developmental delay and autism related disorder in a boy with duplication (17)(p11.2p12).

A patient with a de novo 11q24.2-->qter deletion.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Erratum: Defining the optimal imaging time point for fluorescence-lifetime-based tumor identification using the non-targeting near-infrared dye indocyanine green and post-processed high-dynamic-range images: errata.

Low-Dose Radiotherapy for Benign Achillodynia: A Single Center Experience With Prospective Follow-Up.

Microfluidic Isolation of Aptamers for Intracellular Measurement of Radio-Responsive Proteins.

Microenvironmental remodeling in FLASH radiotherapy.

Open Boari Flap Ureteroneocystostomy in a Radiated Pelvis: A Durable Solution for Complex Distal Ureteric Strictures.

Definitive carbon ion radiotherapy for thoracic bone and soft tissue sarcoma.

関連する実験動画

室内のラドン,肺外遺伝的リスク?

関連する概念動画

関連記事